Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$21.69
-0.32-1.45%
At close: -
$21.69
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Comments
Loading...
Integra Lifesciences Analyst Ratings and Price Targets | NASDAQ:IART | Benzinga
Integra Lifesciences Holdings Corp has a consensus price target of $34.36 based on the ratings of 13 analysts. The high is $53 issued by Jefferies on July 12, 2023. The low is $18 issued by B of A Securities on October 7, 2024. The 3 most-recent analyst ratings were released by Citizens Capital Markets, Citigroup, and Truist Securities on February 26, 2025, November 5, 2024, and October 14, 2024, respectively. With an average price target of $26 between Citizens Capital Markets, Citigroup, and Truist Securities, there's an implied 19.87% upside for Integra Lifesciences Holdings Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citizens Capital Markets
Citigroup
Truist Securities
B of A Securities
JMP Securities
1calculated from analyst ratings
Analyst Ratings for Integra Lifesciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/26/2025 | Buy Now | 61.36% | Citizens Capital Markets | David Turkaly53% | $35 → $35 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/05/2024 | Buy Now | 1.43% | Citigroup | Joanne Wuensch75% | $16 → $22 | Maintains | Sell | Get Alert |
| 10/14/2024 | Buy Now | -3.18% | Truist Securities | Richard Newitter74% | $26 → $21 | Maintains | Hold | Get Alert |
| 10/07/2024 | Buy Now | -17.01% | B of A Securities | Craig Bijou74% | $26 → $18 | Maintains | Underperform | Get Alert |
| 10/07/2024 | Buy Now | — | BTIG | Ryan Zimmerman73% | — | Upgrade | Sell → Neutral | Get Alert |
| 10/01/2024 | Buy Now | -26.23% | Citigroup | Joanne Wuensch75% | $20 → $16 | Maintains | Sell | Get Alert |
| 08/28/2024 | Buy Now | -7.79% | BTIG | Ryan Zimmerman73% | $22 → $20 | Maintains | Sell | Get Alert |
| 08/22/2024 | Buy Now | -7.79% | Citigroup | Joanne Wuensch75% | $23 → $20 | Maintains | Sell | Get Alert |
| 07/30/2024 | Buy Now | 61.36% | JMP Securities | David Turkaly53% | $40 → $35 | Maintains | Market Outperform | Get Alert |
| 07/30/2024 | Buy Now | 19.87% | Truist Securities | Richard Newitter74% | $32 → $26 | Maintains | Hold | Get Alert |
| 07/30/2024 | Buy Now | 6.04% | Citigroup | Joanne Wuensch75% | $30 → $23 | Downgrade | Neutral → Sell | Get Alert |
| 07/30/2024 | Buy Now | 1.43% | BTIG | Ryan Zimmerman73% | → $22 | Downgrade | Neutral → Sell | Get Alert |
| 07/16/2024 | Buy Now | 47.53% | Truist Securities | Richard Newitter74% | $25 → $32 | Maintains | Hold | Get Alert |
| 07/15/2024 | Buy Now | 24.48% | Morgan Stanley | Drew Ranieri45% | $24 → $27 | Maintains | Underweight | Get Alert |
| 07/10/2024 | Buy Now | 38.31% | Citigroup | Joanne Wuensch75% | $28 → $30 | Maintains | Neutral | Get Alert |
| 05/22/2024 | Buy Now | 29.09% | Citigroup | Joanne Wuensch75% | $24 → $28 | Maintains | Neutral | Get Alert |
| 05/07/2024 | Buy Now | 10.65% | Morgan Stanley | Drew Ranieri45% | $37 → $24 | Maintains | Underweight | Get Alert |
| 05/07/2024 | Buy Now | 84.42% | JMP Securities | David Turkaly53% | $49 → $40 | Maintains | Market Outperform | Get Alert |
| 05/07/2024 | Buy Now | 15.26% | Wells Fargo | Vik Chopra44% | $45 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/07/2024 | Buy Now | 15.26% | Truist Securities | Richard Newitter74% | $37 → $25 | Maintains | Hold | Get Alert |
| 05/07/2024 | Buy Now | 19.87% | B of A Securities | Craig Bijou74% | $42 → $26 | Maintains | Underperform | Get Alert |
| 04/03/2024 | Buy Now | 75.2% | Citigroup | Joanne Wuensch75% | $38 → $38 | Upgrade | Sell → Neutral | Get Alert |
| 03/01/2024 | Buy Now | 89.03% | Truist Securities | Richard Newitter74% | $46 → $41 | Maintains | Hold | Get Alert |
| 02/29/2024 | Buy Now | 125.91% | JMP Securities | David Turkaly53% | $55 → $49 | Maintains | Market Outperform | Get Alert |
| 12/22/2023 | Buy Now | 112.08% | Truist Securities | Richard Newitter74% | $44 → $46 | Maintains | Hold | Get Alert |
| 12/14/2023 | Buy Now | 153.57% | JMP Securities | David Turkaly53% | $55 → $55 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/14/2023 | Buy Now | 102.86% | Truist Securities | Richard Newitter74% | $39 → $44 | Maintains | Hold | Get Alert |
| 12/05/2023 | Buy Now | 125.91% | Wells Fargo | Larry Biegelsen69% | $40 → $49 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/14/2023 | Buy Now | 130.52% | CL King | Kristen Stewart50% | → $50 | Initiates | → Buy | Get Alert |
| 10/26/2023 | Buy Now | 79.81% | Truist Securities | Richard Newitter74% | $41 → $39 | Maintains | Hold | Get Alert |
| 10/26/2023 | Buy Now | 70.59% | Morgan Stanley | Drew Ranieri45% | $44 → $37 | Maintains | Underweight | Get Alert |
| 08/24/2023 | Buy Now | 102.86% | Morgan Stanley | Drew Ranieri45% | → $44 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/28/2023 | Buy Now | 176.63% | JMP Securities | David Turkaly53% | $65 → $60 | Maintains | Outperform | Get Alert |
| 07/19/2023 | Buy Now | 121.3% | Truist Securities | Richard Newitter74% | $44 → $48 | Maintains | Hold | Get Alert |
| 07/12/2023 | Buy Now | 144.35% | Jefferies | Matthew Taylor67% | $58 → $53 | Upgrade | Hold → Buy | Get Alert |
| 06/08/2023 | Buy Now | — | Argus Research | David Toung71% | — | Downgrade | Buy → Hold | Get Alert |
| 05/31/2023 | Buy Now | 98.25% | Morgan Stanley | Drew Ranieri45% | $59 → $43 | Maintains | Equal-Weight | Get Alert |
| 05/30/2023 | Buy Now | 102.86% | Truist Securities | Richard Newitter74% | $54 → $44 | Reiterates | Hold → Hold | Get Alert |
| 05/26/2023 | Buy Now | 199.68% | JMP Securities | David Turkaly53% | → $65 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/24/2023 | Buy Now | 98.25% | JP Morgan | Robbie Marcus67% | $56 → $43 | Downgrade | Neutral → Underweight | Get Alert |
| 05/23/2023 | Buy Now | 79.81% | Citigroup | Joanne Wuensch75% | $59 → $39 | Downgrade | Neutral → Sell | Get Alert |
| 05/18/2023 | Buy Now | 148.96% | Truist Securities | Richard Newitter74% | $58 → $54 | Maintains | Hold | Get Alert |
| 04/27/2023 | Buy Now | 199.68% | JMP Securities | David Turkaly53% | $75 → $65 | Maintains | Outperform | Get Alert |
| 04/17/2023 | Buy Now | 185.85% | Truist Securities | Richard Newitter74% | $58 → $62 | Maintains | Hold | Get Alert |
| 02/23/2023 | Buy Now | 172.01% | Citigroup | Joanne Wuensch75% | $60 → $59 | Maintains | Neutral | Get Alert |
| 01/06/2023 | Buy Now | 172.01% | Morgan Stanley | Drew Ranieri45% | $50 → $59 | Maintains | Equal-Weight | Get Alert |
| 12/20/2022 | Buy Now | 167.4% | Truist Securities | Richard Newitter74% | $52 → $58 | Maintains | Hold | Get Alert |
| 12/12/2022 | Buy Now | 176.63% | Citigroup | Joanne Wuensch75% | $50 → $60 | Maintains | Neutral | Get Alert |
| 10/27/2022 | Buy Now | 245.78% | JMP Securities | David Turkaly53% | $85 → $75 | Maintains | Market Outperform | Get Alert |
| 10/27/2022 | Buy Now | 130.52% | Morgan Stanley | Drew Ranieri45% | $49 → $50 | Maintains | Equal-Weight | Get Alert |
| 10/26/2022 | Buy Now | 139.74% | Truist Securities | Richard Newitter74% | $46 → $52 | Maintains | Hold | Get Alert |
| 10/17/2022 | Buy Now | 112.08% | Truist Securities | Richard Newitter74% | $60 → $46 | Maintains | Hold | Get Alert |
| 10/12/2022 | Buy Now | 121.3% | Jefferies | Matthew Taylor67% | → $48 | Initiates | → Hold | Get Alert |
| 10/11/2022 | Buy Now | 125.91% | Morgan Stanley | Drew Ranieri45% | $58 → $49 | Maintains | Equal-Weight | Get Alert |
| 08/25/2022 | Buy Now | 167.4% | Morgan Stanley | Drew Ranieri45% | $59 → $58 | Maintains | Equal-Weight | Get Alert |
| 07/25/2022 | Buy Now | 172.01% | Morgan Stanley | Drew Ranieri45% | → $59 | Initiates | → Equal-Weight | Get Alert |
| 07/20/2022 | Buy Now | 158.18% | Truist Securities | Richard Newitter74% | $70 → $56 | Maintains | Hold | Get Alert |
| 05/17/2022 | Buy Now | 208.9% | Citigroup | Joanne Wuensch75% | $70 → $67 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Integra Lifesciences (IART) stock?
The latest price target for Integra Lifesciences (NASDAQ:IART) was reported by Citizens Capital Markets on February 26, 2025. The analyst firm set a price target for $35.00 expecting IART to rise to within 12 months (a possible 61.36% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Integra Lifesciences (IART)?
The latest analyst rating for Integra Lifesciences (NASDAQ:IART) was provided by Citizens Capital Markets, and Integra Lifesciences reiterated their market outperform rating.
When was the last upgrade for Integra Lifesciences (IART)?
The last upgrade for Integra Lifesciences Holdings Corp happened on October 7, 2024 when BTIG raised their price target to N/A. BTIG previously had a sell for Integra Lifesciences Holdings Corp.
When was the last downgrade for Integra Lifesciences (IART)?
The last downgrade for Integra Lifesciences Holdings Corp happened on July 30, 2024 when Citigroup changed their price target from $30 to $23 for Integra Lifesciences Holdings Corp.
When is the next analyst rating going to be posted or updated for Integra Lifesciences (IART)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Integra Lifesciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Integra Lifesciences was filed on February 26, 2025 so you should expect the next rating to be made available sometime around February 26, 2026.
Is the Analyst Rating Integra Lifesciences (IART) correct?
While ratings are subjective and will change, the latest Integra Lifesciences (IART) rating was a reiterated with a price target of $35.00 to $35.00. The current price Integra Lifesciences (IART) is trading at is $21.69, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.